Evaluating Pharmaceuticals for Health Policy in Low and Middle Income Country Settings

Evaluating Pharmaceuticals for Health Policy and Reimbursement

Volumn , Issue , 2007, Pages 227-243

  Creese, Andrew ^a   Kotwani, Anita ^b   Kutzin, Joseph ^a   Pillay, Anban ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

^c Pharmaceutical Economic Evaluations   (South Africa)

Author keywords

Health budget; Health policy; High income countries; Per capita pharmaceutical spending; Pharmaceutical evaluation

Indexed keywords

EID: 51349151939     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994719.ch14     Document Type: Chapter

References (9)

1. WHO. World health report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: WHO, 2002.
2. World Bank. World development indicators 2000. Washington, DC: The World Bank Group, 2000.
3. WHO. National Health Accounts database. Geneva, Switzerland: WHO, 2003.
4. Jacobzone S. Pharmaceutical policies in OECD countries: reconciling social and industrial goals. Labour market and social policy occasional papers no. 40. April 2000. DEELSA/ELSA/WD(2000)1.
5. EDM/WHO. World Drugs Situation Survey, 1999.
6. Kutzin J, Ibraimova A, Kadyrova N. Innovations in resource allocation, pooling and purchasing in the Kyrgyz health system. Manas health policy analysis project, research paper, 21 August 2002. WHO, Ministry of Health, Department of Reform Coordination and Implementation, Bishkek, Kyrgyztan, 2002.
7. Government of India, National Pharmaceutical Pricing Authority. Modifications in Drug Policy, 1986. http://www.nppaindia.nic.in/drug_pol86/modif86/mod1.html (accessed 6 February 2004).
8. Government of India, National Pharmaceutical Pricing Authority homepage. http://www.nppaindia.nic.in/index1.html (accessed 6 February 2004).
9. WHO-India Essential Drugs Programme, Activity Report, January 1998- December 1999. World Health Organization, New Delhi and Delhi Society for Promotion of Rational Use of Drugs.